| Recruiting | Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms NCT04661215 | Johns Hopkins Bloomberg School of Public Health | — |
| Recruiting | Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis NCT07324785 | Northern Jiangsu People's Hospital | — |
| Not Yet Recruiting | Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Saf NCT06340828 | The Second Hospital of Nanjing Medical University | N/A |
| Recruiting | Washed Microbiota Transplantation for Diabetic Gastroparesis NCT06340217 | The Second Hospital of Nanjing Medical University | N/A |
| Recruiting | Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis NCT06836557 | Vanda Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | Gastroparesis in type2 Diabetic Patient NCT05584462 | Assiut University | — |
| Unknown | Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis NCT05935852 | University of Erlangen-Nürnberg Medical School | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis NCT05832151 | CinDome Pharma, Inc. | Phase 2 |
| Enrolling By Invitation | Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls NCT05812339 | University of Calgary | — |
| Recruiting | Thoracic Neuromodulation for Diabetic Gastroparesis NCT05273788 | Medical University of South Carolina | Phase 1 |
| Completed | Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot S NCT04706832 | Augusta University | EARLY_Phase 1 |
| Completed | A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopa NCT04303195 | Neurogastrx, Inc. | Phase 2 |
| Terminated | A Scintigraphy Study in Adults With Diabetic Gastroparesis NCT04208698 | CinDome Pharma, Inc. | Phase 2 |
| Completed | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis NCT04028492 | Vanda Pharmaceuticals | Phase 3 |
| Unknown | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients NCT03900325 | Bird Rock Bio, Inc. | Phase 2 |
| Terminated | Rifaximin in Patients With Diabetic Gastroparesis NCT04254549 | Mayo Clinic | Phase 2 |
| Completed | Gastroparesis Registry 3 NCT03680859 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Di NCT03544229 | Millennium Pharmaceuticals, Inc. | Phase 2 |
| Terminated | Docusate/Senna for the Treatment of Diabetic Gastroparesis NCT03342157 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants NCT03281577 | Takeda | Phase 2 |
| Withdrawn | Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms NCT03376399 | Baylor Research Institute | — |
| Completed | G-POEM for Treatment of Refractory Gastroparesis NCT02732821 | Johns Hopkins University | — |
| Unknown | Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis NCT02452489 | Changchun University of Chinese Medicine | Phase 1 |
| Unknown | Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis NCT02264587 | Liangzhou Wei | Phase 4 |
| Completed | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) NCT02289846 | Ironwood Pharmaceuticals, Inc. | Phase 2 |
| Terminated | Study of Promethazine for Treatment of Diabetic Gastroparesis NCT02130622 | Dartmouth-Hitchcock Medical Center | Phase 2 |
| Completed | Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastr NCT02025751 | Evoke Pharma | Phase 3 |
| Completed | Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gas NCT02025725 | Evoke Pharma | Phase 3 |
| Completed | Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients NCT01916460 | Texas Tech University Health Sciences Center, El Paso | N/A |
| Completed | Biomagnetic Characterization of Gastric Dysrhythmias III NCT03176927 | Vanderbilt University Medical Center | EARLY_Phase 1 |
| Terminated | Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 NCT01664637 | Tranzyme, Inc. | Phase 2 |
| Completed | Gastroparesis Registry 2 NCT01696747 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis NCT01607684 | Martin-Luther-Universität Halle-Wittenberg | Phase 2 |
| Completed | Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis NCT01030341 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Withdrawn | Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis NCT01326117 | Mark Feinglos | Phase 4 |
| Completed | Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive Imaging NCT01919021 | Nottingham University Hospitals NHS Trust | N/A |
| Completed | Transcutaneous Electroacupuncture for Gastroparesis NCT01469286 | Transtimulation Research, Inc | Phase 1 |
| Suspended | Acupuncture for Diabetic Gastroparesis NCT00470795 | Shaare Zedek Medical Center | Phase 3 |
| Completed | Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis NCT00845858 | Evoke Pharma | Phase 2 |
| Terminated | The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gas NCT00874133 | Rabin Medical Center | N/A |
| Completed | Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis NCT01557296 | Göteborg University | Phase 2 |
| Completed | Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention NCT01126034 | University of Pennsylvania | N/A |
| Completed | A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Adm NCT00139893 | UCB Pharma | N/A |
| Withdrawn | Gastric vs Jejunal Feeding in Diabetic Gastroparesis NCT00944593 | University of Zurich | Phase 4 |
| Available | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis NCT04474990 | Vanda Pharmaceuticals | — |